The in-vitro activities of various antibiotics, either alone or in combination with amikacin were assessed in clinical isolates of Pseudomonas aeruginosa. Clinically relevant synergic interactions were most frequent with piperacillin (92%), ceftazidime (87%) and aztreonam (84%), and less frequent with imipenem (35%). Ciprofloxacin-amikacin showed only an additive effect.
No takes yet. Share an insight, caveat, or question.
Gerçeker et al. (1995) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: